747.84003 USD
7.9449
1.05%
Last update Dec 16, 4:20 PM GMT
Market closed
Day range
738.58899
764.98999
Previous close
755.78497
Open
756.69000
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
747.84
7.94
1.05%

Financials

Income statement

Fiscal date 2021 2020 2019 2018
Total reported revenue 115.5M 24.3M 22.2M 10.9M
Cost of revenue
Gross profit
Operating expense
Research & development 115.2M 98.1M 82.4M 45.1M
Selling general and admin 39.7M 36.1M 27.0M 13.7M
Other operating expenses
Operating income -39.4M -109.8M -87.2M -47.9M
Non operating interest income
Income 208K 822K 4.3M 1.9M
Expense 132K 0 182K
Other income expense 8.7M -9.8M
Pretax income -30.6M -109.0M -92.9M -46.0M
Tax provision
Net income -30.6M -109.0M -92.9M -46.0M
Basic EPS -0.5 -2.1 -2.2 -1.4
Diluted EPS -0.5 -2.1 -2.2 -1.4
Basic average shares 58.7M 52.0M 42.0M 33.7M
Diluted average shares 58.7M 52.0M 42.0M 33.7M
EBITDA -28.8M -99.2M -87.4M -45.6M
Net income from continuing op. -30.6M -109.0M -92.9M -46.0M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 8 hours 43 minutes

22:31
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).